COMMENTARY

Stroke Update Part 2: JUPITER Trial Results

Mark J. Alberts, MD

Disclosures

March 19, 2009


This feature requires the newest version of Flash. You can download it here.

Click here if you already have the newest version of Flash installed.
This feature requires the newest version of Flash. You can download it here.

Discuss Stroke Update Part 2: JUPITER Trial Results


Citations: Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207. Epub 2008 Nov 9.

Paul M Ridker, Robert Glynn, Brigham and Women's Hospital, Boston, MA; on behalf of the JUPITER Trial Study group. Rosuvastatin in the Prevention of Stroke Among Men and Women with Elevated Levels of CReactive Protein: the JUPITER trial. Program and abstracts of the International Stroke Conference; February 18-20, 2009; San Diego, California. Abstract 140. Available at: http://strokeconference.americanheart.org/sc_includes/pdfs/lbOralAbstracts.pdf
Accessed March 17, 2009

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....